Literature DB >> 99486

Interferon inducing activity of polyinosinic acid.

E De Clercq, B D Stollar, M N Thang.   

Abstract

Although poly(I) is generally considered to be inactive as an interferon inducer, we have found several authentic poly(I) preparations to be effective inducers. Their interferon inducing ability varied considerably from one cell system to another. In human diploid fibroblasts, primed with interferon and superinduced by cycloheximide and actinomycin D, all active poly(I) samples proved nearly as effective in inducing interferon as poly(I).poly(C). In primary rabbit kidney cell cultures, the active poly(I) samples were either as active, or 3 to 30 times less active than poly(I).poly(C). In intact rabbits they were 100 times less active than poly(I).poly(C). Except for one particular sample, all active poly(I) preparations were inferior to poly(I).poly(C) when assayed for interferon induction in interferon-treated mouse L cells; in DEAE-dextran-treated L cells, they induced little, if any, interferon. The poly(I) inducers of interferon were considerably more susceptible to degradation by TI ribonuclease, pancreatic ribonuclease and human serum nuclease(s) than was poly(I).poly(C) when assayed under the same conditions. Due to their limited half-life time in biological fluids, poly(I) analogues such as those described here may offer a greater safety margin in clinical use than poly(I).poly(C).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99486     DOI: 10.1099/0022-1317-40-1-203

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Interferon induction by mismatched analogues of polyinosinic acid . polycytidylic acid [(Ix,U)n.(C)n].

Authors:  E De Clercq; G F Huang; B Bhooshan; G Ledley; P F Torrence
Journal:  Nucleic Acids Res       Date:  1979-12-11       Impact factor: 16.971

2.  Structural requirements of polynucleotides for the activation of (2' - 5')An polymerase and protein kinase.

Authors:  C Baglioni; M A Minks; E De Clercq
Journal:  Nucleic Acids Res       Date:  1981-10-10       Impact factor: 16.971

3.  Studies on the mode of action of single-stranded polynucleotides which are antiviral against encephalomyocarditis virus infection of mice.

Authors:  N Stebbing
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.

Authors:  L Martínez-Gil; P H Goff; R Hai; A García-Sastre; M L Shaw; P Palese
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

5.  PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.

Authors:  Julia Koerner; Dennis Horvath; Valerie L Herrmann; Anna MacKerracher; Bruno Gander; Hideo Yagita; Jacques Rohayem; Marcus Groettrup
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.